Latest TomoDirect Radiotherapy Technology Stories
TomoTherapy Incorporated (NASDAQ: TOMO) today announced that it has received FDA 510(k) clearance for its TomoDirect(TM) radiation therapy technology. TomoDirect is an innovative new discrete-angle, sliding-beam delivery mode for the Hi-Art(R) treatment system.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).